Yoshikazu Yonemitsu
Corporate Officer/Principal at Kyushu University
Yoshikazu Yonemitsu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Kyushu University | Corporate Officer/Principal | 01/04/1990 | - |
Career history of Yoshikazu Yonemitsu
Former positions of Yoshikazu Yonemitsu
| Companies | Position | Start | End |
|---|---|---|---|
GAIA BioMedicine Inc.
 GAIA BioMedicine Inc. Miscellaneous Commercial ServicesCommercial Services GAIA BioMedicine Inc. engages in the development of regenerative medicine and other product development. Its products include medicines for cell and gene therapy. It also offers services on drug screening and advance medical support. The company was founded by Yoshikazu Yonemitsu in October 2015 and is headquartered in Fukuoka, Japan. | Founder | 01/10/2015 | - |
| TELLA, INC. | Director/Board Member | 01/07/2010 | - |
Statistics
International
| Japan | 4 |
Operational
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
GAIA BioMedicine Inc.
GAIA BioMedicine Inc. Miscellaneous Commercial ServicesCommercial Services GAIA BioMedicine Inc. engages in the development of regenerative medicine and other product development. Its products include medicines for cell and gene therapy. It also offers services on drug screening and advance medical support. The company was founded by Yoshikazu Yonemitsu in October 2015 and is headquartered in Fukuoka, Japan. | Commercial Services |
- Stock Market
- Insiders
- Yoshikazu Yonemitsu
- Experience
